BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| fucoidan {Brown Algae Extract} - Bacteroidia |
📓
Anti-obesity effects of Laminaria japonica fucoidan in high-fat diet-fed mice vary with the gut microbiota structure. Food & function (Food Funct ) Vol: 13 Issue 11 Pages: 6259-6270 Pub: 2022 Jun 6 Epub: 2022 Jun 6 Authors Zhang X , You Y , Wang L , Ai C , Huang L , Wang S , Wang Z , Song S , Zhu B , Publication |
| fucoidan {Brown Algae Extract} - Bacteroidia |
📓
Laminaria japonica Polysaccharide Regulates Fatty Hepatosis Through Bile Acids and Gut Microbiota in Diabetes Rat. Marine biotechnology (New York, N.Y.) (Mar Biotechnol (NY) ) Vol: Issue Pages: Pub: 2024 Aug 29 Epub: 2024 Aug 29 Authors Zhang B , Wang J , Chen X , Xue T , Xin J , Liu Y , Wang X , Li X , Publication |
| fucoidan {Brown Algae Extract} - Bacteroidia |
📓
Fucoidan modulates gut microbiota and immunity in Peyer's patches against inflammatory bowel disease. Carbohydrate polymers (Carbohydr Polym ) Vol: 342 Issue Pages: 122421 Pub: 2024 Oct 15 Epub: 2024 Jun 19 Authors Li JK , Veeraperumal S , Aweya JJ , Liu Y , Cheong KL , Publication |
| fucoidan {Brown Algae Extract} - Bacteroidia |
📓
High-molecular-weight Fucoidan exerts an immune-enhancing effect in RAW 264.7 cells and cyclophosphamide-induced immunosuppression rat by altering the gut microbiome. International immunopharmacology (Int Immunopharmacol ) Vol: 139 Issue Pages: 112677 Pub: 2024 Sep 30 Epub: 2024 Jul 17 Authors Park EJ , Kim JY , Jaiswal V , Park HS , Ki DB , Lee YS , Lee HJ , Publication |
| fucoidan {Brown Algae Extract} - Bacteroidia |
📓
A fucoidan from sea cucumber Pearsonothuria graeffei with well-repeated structure alleviates gut microbiota dysbiosis and metabolic syndromes in HFD-fed mice. Food & function (Food Funct ) Vol: 9 Issue 10 Pages: 5371-5380 Pub: 2018 Oct 17 Epub: Authors Li S , Li J , Mao G , Wu T , Hu Y , Ye X , Tian D , Linhardt RJ , Chen S , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
